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Abstract: Physical exercise is known to have a dose-dependent effect on the immune system and
can result in an inflammatory process in athletes that is proportional to the intensity and duration of
exertion. This inflammatory process can be measured by cell markers such as dendritic cells (DCs),
which, in humans, consist of the myeloid DC (mDCs) and plasmacytoid DC (pDCs) subpopulations.
The aim of this study was to measure DC differentiation to determine the possible anti-inflammatory
effects, after intense aerobic effort, of the intake of a 25 mL extra-virgin olive oil supplement. Three
healthy sports-trained subjects went through resistance exercise loads on two days separated by a
week: on one day after active supplement intake and on the other day after placebo supplement
intake. The results show that the highest increase (77%) in the percentage of mDCs as a proportion
of pDCs was immediately after testing. Independently of the supplement taken, mature mDCs
showed a decreasing trend between the test one hour after and 24 h after testing ended. Nevertheless,
measured in terms of the coefficient of variation, only the decrease (46%) for extra-virgin olive oil
supplementation was statistically significant (95% CI: 30–62%; p = 0.05). In conclusion, an extra-virgin
olive oil supplement could reduce the inflammatory impact of intense aerobic effort and improve
recovery at 24 h.
Keywords: olive oil; physical exercise; inflammation; dendritic cells
1. Introduction
Olive oil is the main cornerstone of the Mediterranean diet and is the most important
differentiating factor compared to other countries as a source of polyphenols [1]. Olive
oil consumption in Mediterranean countries is estimated between 30–50 g·day−1. A daily
consumption of 50 g of olive oil with an average phenol concentration of 180 mg·kg−1
would result in an estimated consumption of approximately 9 mg·day−1 [2].
In Mediterranean countries, olive oil has always been considered beneficial for health,
and this assumption has been confirmed by the results of numerous studies. Olive oil con-
sumption, specifically the extra-virgin variety, is associated with a reduced inflammation,
cardiovascular disease, cancer, and mortality [2–8]. These benefits may be related to its
source of polyphenols, which have been shown to possess antimicrobial, antioxidant, and
anti-inflammatory systemic properties [6,9–12].
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Physical exercise can have both positive and negative effects on immune system
depending on its duration and intensity [13–15]. Previous research has shown that during
prolonged physical exercise cortisol release from the adrenal cortex predominates, resulting
in modulation of cytokine secretion, alteration of circulating white blood cells, and efficacy
of antigen presentation.
Dendritic cells (DCs), which are derived from bone marrow progenitor cells, are
potent antigen-presenting cells that play a major role in initiating and maintaining innate
and adaptive immunity. DCs form a dense network in nearly all body tissues [16], and
can be found in an immature state as DC precursors in the blood. Their main function
is to detect potentially harmful foreign antigens in the internal environment [17]. As a
consequence of antigen uptake and the presence of inflammatory stimuli, immature DCs
undergo terminal differentiation.
Humans have two different blood circulating DCs subpopulations: myeloid DCs
(mDCs) and plasmacytoid DCs (pDCs). The mDCs, similar to monocytes, can be further
divided into the more common myeloid type 1 DCs (mDC1), a major stimulator of T-cells,
and the extremely rare myeloid type 2 DCs (mDC2s), which may have a function in
fighting wound infection. The pDCs, which look like plasma cells, are often referred to as
interferon-producing cells but have certain characteristics similar to mDCs [18].
Several studies have explored the effects of acute bouts of exercise on DC differentia-
tion [19–25]. When exercise intensity remains constant, the pattern of substrate utilization
changes. Hence, the longer the time spent exercising, the higher the contribution of fat as an
energy substrate. In prolonged exercise, as glycogen stored in working muscles is depleted,
plasma fatty-acid oxidation increases, due to an increase in circulating catecholamines
(adrenalin and noradrenalin) and a decrease in circulating insulin. The catecholamines and
insulin play specific roles in stimulating and inhibiting, respectively, the lipolysis process.
Compared to untrained athletes, those trained in endurance sports use less muscle
glycogen and have a greater capacity to use fatty acids as an energy source, which explains
why trained athletes perform better in endurance events [26,27]. Thus, fat supplementation
could serve as a nutritional strategy to reduce muscle glycogen depletion in endurance
exercise, since the rate of oxidation of free fatty acids in muscle depends in part on their
concentration levels in blood plasma [28].
Extra-virgin olive oil is a source of fatty acids that is rich in polyphenols [1]. A study
assessing the beneficial effects of 25 mL dose of olive oil found that it neither induces
significant postprandial lipaemia nor increases markers of oxidation in-vivo [29]. To the
best of our knowledge, there is a gap in the literature regarding the effects of the use of
extra-virgin olive oil in endurance sports. Therefore, the main objective of this study was
to evaluate the anti-inflammatory effects of an acute fat supplementation rich in a natural
anti-inflammatory substance—extra-virgin olive oil with a high polyphenol content—in
individuals performing high-intensity exercise with an energy cost equivalent to 2000 kcal.
2. Materials and Methods
2.1. Participants
The participants volunteering in the study were 3 physically active men who perform
recreational sports training 3 to 5 days a week. Informed consent was obtained in each
case, and the study protocol, compliant with the principles of the Declaration of Helsinki,
was approved by the Institutional Ethics Committee.
2.2. Study Design
In this randomized cross-over controlled double-blind trial, two separate effort test
sessions were carried out separated by one week. No physical activity was performed the
day before testing. Supplementation in the form of a gel at a temperature of about 10 ◦C
was orally administered blind to each of the three subjects: an active supplement with extra-
virgin olive oil or a placebo supplement without extra-virgin olive oil. In what follows,
the subjects who received the supplement with olive oil and the placebo are referred
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to as treated and non-treated subjects, respectively. The order of supplementation was
randomized using a random number generator (i.e., day 1 = treated/day 2 = non-treated
or day 1 = non-treated/day 2 = treated).
2.3. Supplements
The active and placebo supplements were prepared—in the same laboratory of the
Department of Physiological Sciences (University of Barcelona)—using orange juice, with
added modified starch to achieve a gel texture. The active supplement also included
extra-virgin olive oil (Table 1). The calorific value and fat content of the active supplement
were much higher than in the placebo.
Table 1. Supplement ingredients and nutritional content.
Active Supplement Placebo Supplement
Ingredients
100 mL commercial orange juice
8 g modified starch
25 mL extra-virgin olive oil
100 mL commercial orange juice
8 g modified starch
Energy (Kcal) 277 52.8
Fat (g) 25 0.1
Carbohydrates (g) 12.6 12.6
2.4. Protocol
Effort testing was performed in the laboratory of the Department of Physiological
Sciences (University of Barcelona) at an ambient temperature of 22–24 ◦C and with relative
humidity at 55–65%.
A venous catheter was placed in a superficial forearm vein to facilitate the collection
of blood samples at five different times. On each occasion, 2–3 mL of peripheral venous
blood was extracted into a tube to determine the following: monocyte subpopulations, DC
phenotype, and lactate concentration (lithium heparin tubes); biochemical profile (Serum
Sep Clot Activator tubes); and complete blood count (K3EDTA tubes).
The protocol stages were as follows (see also Figure 1):
Step 1. Supplement 1. Blood was sampled one hour before the test (T0) and the
supplement (active or placebo, depending on the day) was administered.
Step 2. Maximal test. Participants performed a maximal incremental exercise test
starting at 6.2 km/h for 4 min, after which grade increased by 1% every 4 min, up to
exhaustion point. Blood was sampled immediately after the end of the test (T1).
Step 3. Supplement 2. Recovery time of 5 min. A half supplement (active or placebo,
depending on the day) was administered with 500 mL of water.
Step 4. Submaximal test. Maximum distance (speed controlled by the subject) cov-
ered in 45 min, with slope fixed at 50% of peak (e.g., 10% if 20% of the maximum slope
was reached in the maximal test). Blood was sampled immediately after (T2) and one hour
after (T3) this test.
Step 5. Follow-up. Blood was sampled 24 h after the test (T4).
2.5. Dietary Assessment
The volunteers consumed a specific diet, based on standard energy requirements, the
day before testing and at breakfast on the day of testing to ensure no nutritional variability
in macronutrient intake of antioxidants, especially phenolic compounds. The diet, designed
using the EasyDiet online software, was based on approximately 3000 kcal/day (60%
carbohydrates, 25% fat, and 15% proteins).
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2.6. Analytical Procedures
2.6.1. Physical Test and Metabolic Analysis
A treadmill was used as the ergome er (Quasar, HP Cosmos Sports and Medical Gmbh,
Nussdorf-Traunstein, Germany). Electr cardiographi (ECG) parameters were measured
using specific sof ware (Cardi Sca v.4.0, DM Software, Stateline, NV, USA). Arm blood
pressure (BP) was taken manu lly using a clinical sphygmomanometer (Erkameter 3000,
Erka, Bad Tölz, Germany). O2 uptake and CO2 production were measured by an automatic
gas analysis system (Metasys TR-plus, Brainware SA, La Valette, France) equipped with a
pneumotach and a two-way mask (Hans Rudolph, Shawnee, KS, USA). Gas and volume
calibrations were performed before each test according to manufacturer guidelines.
2.6.2. Antibodies and Reagents
The following monoclonal antibodies were obtained from Invitrogen (Molecular
Probes, Eugene, OR, USA): CD14 TRI-COLOR conjugate and human CD16-fluorescein
isothiocyanate (FITC). Fluorescence-activated cell sorting (FACS) lysing solution and Cell-
FIX were purchased from Becton Dickinson Pharmingen (San Diego, CA, USA), along
with other monoclonal antibodies: anti-human CD40-FITC, CD80-FITC, CD83-FITC, CD86-
FITC, and human leukocyte antigen D-related (HLA-DR) phycoerythrin (PE). Human
Hematopoietic Lineage APC Cocktail, anti-human CD123-FITC, and CD11c-PE-Cy5 were
obtained from e-Bioscience (San Diego, CA, USA). Finally, the Cytometric Bead Array
(CBA) Human Inflammatory Cytokines Kit was obtained from BD Biosciences (San Diego,
CA, USA).
2.6.3. Flow Cytometry Analysis of DC Phenotype, Co-Stimulatory Molecules, and Subsets
For DC identifi ation, peripheral blood was stained by Human Hematopoietic Lineage
APC Cocktail, anti-human CD123-FITC and CD11c-PE-Cy5, anti-human CD40-FITC, CD80-
FITC, CD83-FITC, CD86-FITC, and HLA-DR PE. Whole blood (100 µL) was incubated with
different combinations of antibodies for 20 min in darkness at room temperature. Red blood
cells were lysed in 2 mL of FACS lysing solution for 10 min at room temperature. Samples
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were immediately washed twice with phosphate buffered saline (PBS), re-suspended with
250 µL of CellFIX and stored at 4 ◦C until the flow cytometry analysis. FACS was performed
using FACS Canto and analyzed with FACS Diva software (Becton Dickinson Pharmingen).
DCs were defined as Lineage−/HLA-DR+, the myeloid subset (mDCs) as CD11c+/CD123−
and the plasmacytoid subset (pDCs) as CD11c−/CD123+. In both DC subsets, different
co-stimulatory molecule expression (CD80, CD40, CD83, and CD86) were used to define
their maturation state.
2.6.4. Flow Cytometry Analysis of Monocyte Subpopulations in Peripheral Blood
To identify the monocyte subpopulations, whole blood (100 µL) was incubated with
human CD14 TRI-COLOR conjugate and human CD16-FITC for 20 min in darkness at
room temperature. Red blood cells were lysed, using 2 mL of FACS lysing solution, for
10 min at room temperature, after which samples were immediately washed twice with
PBS, re-suspended with 250 µL of CellFIX and stored at 4 ◦C until flow cytometry analysis.
Figure 2 shows a representative distribution of the monocyte subpopulations as measured
by flow cytometry in the peripheral blood of a volunteer after an exercise bout. The
monocyte population (P1) was defined for forward scatter FSC-A and side scatter SSC-A.
Monocyte subsets within the P1 population were subsequently assessed using a CD14
Per-CP/CD16-FITC dot plot.
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Figure 2. Representative flow cytometry analysis of monocyte subsets in the peripheral blood of a volunteer after an exercise
bout. (A). Monocytes gated in P1 in FCS-A/SSC-A. (B). Monocyte subsets in P1 assessed using a CD14 Per-CP/CD16-FITC
dot plot.
2.6.5. Flow Cytometry Cell Cytokine Analysis
Interleukin (IL)-1β, -6, -8, -10, -12p70, and tumor necrosis factor (TNF)-α secreted
protein levels from the plasma were measured quantitatively using the CBA Human
Inflammatory Cytokines Kit. Flow cytometry analysis was performed using FACS Canto
and cytokines’ concentrations were analyzed by FCAP Array™ software. Cytokines were
quantified for each subject’s plasma at each monitoring point. The main results are shown
in supplementary material.
2.7. Statistical Analysis
Each analysis was performed three times and representative data were compiled. The
non-parametric Friedman test for repeated measures was used to evaluate mDC and pDC
changes between the three analyses. Statistical analyses were conducted using Statistical
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Package for the Social Sciences (SPSS) v.14.0 (IBM SPSS Statistics, Chicago, IL, USA).
Statistical significance was set at an alpha level < 0.05.
3. Results
3.1. Participants
Three healthy, physically active male volunteers were selected to participate in the
study by means of non-probabilistic intentional sampling. The volunteers were aged
between 35 and 51 years, with height between 165 and 181 cm, weight between 65 and
94 kg, and body mass index (BMI) between 22.39 and 28.75 (Table 2).
Table 2. Subject characteristics.
Subject #1 #2 #3
Age (years) 51 34 39
Weight (kg) 94 65 71
Height (cm) 181 165 178
BMI (kg·m−2) 28.75 23.90 22.39
3.2. Analysis of pDC and mDC Populations and Monocytes after Exercise
DC populations were analyzed by FACS to determine mature forms in the peripheral
blood of the subjects according to forward-/side-scatter profiles and specific maturation
markers established in a previous study [30], namely CD40, CD80, CD83, CD86, and HLA-
DR. Mature DCs were differentiated as mDC and pDC subpopulations, depending on
maturation subtype according to the specific phenotypic markers Lin− HLADR+ CD11+/−
CD123−/+ at the different monitoring points (T0, T1, T2, T3, and T4) (Figure 3). At T3,
a strong maturation response was observed for mDCs (p < 0.05) that was mirrored by a
decrease in pDCs. Monocytes were also gated from blood samples and analyzed by FACS
(CD14+/++ CD16+/−) to differentiate pro-inflammatory from transitional monocytes
(Figure 4). Results show an increase in pro-inflammatory monocytes during exercise with
no variation in cardiovascular risk-related monocytes.
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To evaluate olive oil supplement in DC maturation after intense physical exercise, 
mDCs and pDCs in the treated and non-treated subjects were identified at the different 
monitoring points. Mature DCs as a proportion of mDCs increased most rapidly from T3 
and then declined towards T4 (Figure 5). Nevertheless, this decrease (∆T3-T4/∆T3-T2) 
measured in terms of the coefficient of variation (CV) was only significant for treated 
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Figure 5. Impact of olive oil supplement on mature dendritic cells (DCs) (mDC: red line; pDC:
blue line) during and after intense exercise ((A). Non-treated group and (B). Treated group). The
percentage of myeloid DCs (mDCs) increased in both treated and non-treated subjects from T2 to T3.
The decrease in mDCs at T4 (24 h after the exercise) was greater for the treated subjects.
Table 3. Coefficient of variation (∆T3-T4/∆T3-T2) evaluating recovery from exercise-induced inflam-
mation in treated and non-treated subjects.
Subjects Non-Treated Treated
T2 T3 T4 T2 T3 T4
#1 56.4 57.8 56 62.6 77.9 37.1
CV1 1.29 2.63
#2 46.5 72.3 64.9 38 67.8 35.9
CV2 0.29 1.1
#3 24.5 80.5 48.5 61.6 65.7 48.7
CV3 0.57 4.15
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3.4. Metabolic Data
Metabolic data results were not statistically significant (Table 4).
Table 4. Metabolic data for treated and non-treated subjects.
Treated Non-Treated
Subject #1 #2 #3 #1 #2 #3
MAXIMAL TEST
VE (L·min−1) 154.1 78.8 152.4 146.5 93.5 132.9
VO2/Kg (mL·kg·min−1) 39.3 39.6 59 39.4 47.6 52.5
QR 1.127 1.064 1.13 1.121 1.016 1.087
VCO2 (L·min−1) 4.17 2.74 4.73 4.15 3.14 4.05
FC (lat·min−1) 159 177 173 152 183 171
Metabolic rate
(kcal·day−1) 27,679 19,021 31,356 27,690 22,600 27,657
SUBMAXIMAL TEST
1M-45 4947 4924 5218 5072 4663 5058
1M-45-O2 275.6 268.7 392.4 279.5 294.3 360.3
1M-45-QR 0.977 0.875 0.907 0.968 0.924 0.89
%VO2 max 77.1 74.2 77.1 79.9
64.01M-45-kcal 641.3 429.8 726.8 666 445.5 645.8
Kcal·metres 0.130 0.087 0.139 0.131 0.096 0.128
4. Discussion
Physical exercise is known to have a dose-dependent effect on the immune system.
While regular moderate exercise has the potential to enhance immune functions, excessive
and prolonged exercise may induce immunosuppression [31].
Regular moderate exercise is considered to produce long-term anti-inflammatory
effects [32]. In contrast, strenuous exercise has been shown to induce rapid systemic
cytokine release and to activate neutrophils and monocytes [33,34]. This inflammatory
response seems to be balanced by an enhanced concomitant release of anti-inflammatory
defenses such as interleukin 10 (IL-10). A balance between pro- and anti-inflammatory
cytokines has been argued to prevent or restrict exercise-induced oxidative stress [33].
In the present study, we analyzed the impact of strenuous physical exercise on the
number and maturation of peripheral blood DC subsets and on metabolic data and com-
pared the results for the same men when they had received a supplement with extra-virgin
olive oil rich in polyphenols and when they had received a placebo.
The results show that, although metabolic effort was similar, the anti-inflammatory
response was different, with the findings of the present study being, therefore, consistent. In
parallel, the different parameters show a response for this type of effort that is both intense
and long-lasting. Observed was a response that may be related to a reduced nonspecific
immune response, although without statistical or clinical significance.
The impact of physical exercise on the characteristics of mDCs and pDCs has not as
yet been described, although previous studies have examined and determined the acute
effect of exercise on DC differentiation [19–25].
In our study, the impact of physical exercise on mDC and pDC characteristics seems to
be congruent, given that all participants responded in the same direction but with important
differences, in that the percentage of mDCs increased in both groups. Suchánek et al. [21]
analyzed the frequency and absolute numbers of circulating myeloid and plasmacytoid
DCs in peripheral blood and evaluated their maturation status before and after the physical
load in 18 profesional ice-hockey players. However, compared to our results they observed
that both myeloid and plasmacytoid DCs increased significantly.
The results show that the highest increase (77%) as a proportion of mDCs was im-
mediately after testing, whereas DC maturation showed a decreasing tendency from
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immediately after exercise to 24 h after exercise for all individuals, independent of the sup-
plement taken. Nevertheless, measured in terms of the CV, it was only when the subjects
had received extra-virgin olive oil that this decrease (of 46%) proved to be statistically signif-
icant, suggesting that the polyphenol content in the oil affected response. Lackermair et al.
examining the effect of stress on dendritic cell count in a cohort of 100 healthy athletic
males and the influence of a polyphenol-rich beverage [35]. They evaluated both moder-
ate exercise during a 4-week training interval and the strenuous exercise of a marathon
run, 24 h and 72 h after. Marathon running induced a significant increase of circulating
mDCs and a significant decrease of pDCs. However, compared to our results, polyphenol
supplementation did not significantly affect mobilization of dendritic cells.
Bowtell et al. carried out a systematic review that evaluated the effect of fruit-derived
polyphenol supplementation for athlete recovery and performance. Evidence would sug-
gest that acute supplementation with ~300 mg polyphenols 1–2 h prior to exercise may
enhance exercise capacity and/or performance during endurance exercise via antioxidant
and vascular mechanisms. Additionally, supplementation with >1000 mg polyphenols per
day for 3 or more days prior to and following exercise will enhance recovery following
muscle damage via antioxidant and anti-inflammatory mechanisms [36].
Polyphenol supplementation in exercise studies included mainly extracts (multicom-
ponent or purified), juices, infusions, or an increased intake of polyphenol-rich foods [37].
In our study, for the extra-virgin olive oil supplement, we did not quantify the polyphenols
in either the olive oil or in the blood. However, using this kind of inflammation marker,
we can assess the impact of inflammation before, during and 24 h after effort, it was
observed that an extra-virgin oil supplement results in better recovery and an improved
inflammatory state.
Our findings should be discussed in the light of our methodological limitations. First,
the small number of participants and the fact that we only recruited men for this study. The
complexity of the protocol, however, needed motivated volunteers with time availability.
Studies with larger samples would be necessary to confirm our findings, explore individual
differences in responses, and compare sex differences. Second, we did not use biomarkers
to observe physiological oxidative status. However, it has been demonstrated that a 25-mL
dose of extra-virgin olive oil does not induce significant postprandial lipaemia nor does it
increase in vivo oxidation markers [29]. Further research should be conducted to provide
an accurate picture of the effectiveness of extra-virgin olive oil supplement on dendritic
cell maturation after strenuous physical exercise.
5. Conclusions
Strenuous exercise that generates fatigue to exhaustion has short-term proinflamma-
tory implications that decrease immune capacity. The intake of extra-virgin olive oil with
its high polyphenol content seems to reverse the inflammatory state to normal levels of
mDC within 24 h. The data observed in this experiment are an objective basis that allows
exploring the possibilities of DCs as an inflammatory marker against different types of
efforts and evaluating the protective effect of certain supplements.
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